Home
Scholarly Works
Faricimab treatment outcomes with extended dosing...
Conference

Faricimab treatment outcomes with extended dosing and potential for Q20W intervals in DME: post hoc analysis of the 96-week phase 3 YOSEMITE/RHINE trials

Authors

Adam MK; Gibson K; Sim D; Amador M; Hill L; Singer M

Volume

65

Publisher

ASSOC RESEARCH VISION OPHTHALMOLOGY INC

Publication Date

June 1, 2024

Name of conference

Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)

Conference place

WA, Seattle

Conference start date

May 5, 2024

Conference end date

May 9, 2024

Conference proceedings

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Issue

7

ISSN

0146-0404

Labels

Fields of Research (FoR)

Contact the Experts team